News|Articles|July 6, 2026
FDA Action Update, June 2026: Acceptances, Clearances, and Alignments
Author(s)Isabella Ciccone, MPH
Catch up on any of the neurology headlines you may have missed in June 2026, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in June 2026, making a number of decisions on potential new therapeutic agents, including acceptances of new drug applications, reaching alignments, and scheduling an AdComm meeting.
Advertisement
Advertisement